LabGenomics Statistics

Total Valuation

LabGenomics has a market cap or net worth of KRW 201.93 billion. The enterprise value is 170.85 billion.

Market Cap	201.93B
Enterprise Value	170.85B

Important Dates

The next estimated earnings date is Thursday, August 14, 2025.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	n/a

Share Statistics

LabGenomics has 74.24 million shares outstanding. The number of shares has decreased by -0.39% in one year.

Current Share Class	74.24M
Shares Outstanding	74.24M
Shares Change (YoY)	-0.39%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.53%
Owned by Institutions (%)	8.71%
Float	61.85M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.30
PB Ratio	0.96
P/TBV Ratio	1.56
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-8.47
EV / Sales	1.94
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-8.70

Financial Position

The company has a current ratio of 2.08, with a Debt / Equity ratio of 0.23.

Current Ratio	2.08
Quick Ratio	1.98
Debt / Equity	0.23
Debt / EBITDA	n/a
Debt / FCF	-2.49
Interest Coverage	-3.32

Financial Efficiency

Return on equity (ROE) is -9.29% and return on invested capital (ROIC) is -4.24%.

Return on Equity (ROE)	-9.29%
Return on Assets (ROA)	-3.79%
Return on Invested Capital (ROIC)	-4.24%
Return on Capital Employed (ROCE)	-8.04%
Revenue Per Employee	539.27M
Profits Per Employee	-123.71M
Employee Count	163
Asset Turnover	0.29
Inventory Turnover	17.51

Taxes

Income Tax	-4.06B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +27.73% in the last 52 weeks. The beta is 0.68, so LabGenomics's price volatility has been lower than the market average.

Beta (5Y)	0.68
52-Week Price Change	+27.73%
50-Day Moving Average	2,400.60
200-Day Moving Average	2,735.35
Relative Strength Index (RSI)	58.77
Average Volume (20 Days)	13,199,690

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, LabGenomics had revenue of KRW 87.90 billion and -20.16 billion in losses. Loss per share was -271.60.

Revenue	87.90B
Gross Profit	32.24B
Operating Income	-18.09B
Pretax Income	-24.21B
Net Income	-20.16B
EBITDA	-7.95B
EBIT	-18.09B
Loss Per Share	-271.60

Full Income Statement

Balance Sheet

The company has 80.04 billion in cash and 48.95 billion in debt, giving a net cash position of 31.08 billion or 418.70 per share.

Cash & Cash Equivalents	80.04B
Total Debt	48.95B
Net Cash	31.08B
Net Cash Per Share	418.70
Equity (Book Value)	210.87B
Book Value Per Share	2,840.45
Working Capital	68.83B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -16.93 billion and capital expenditures -2.70 billion, giving a free cash flow of -19.63 billion.

Operating Cash Flow	-16.93B
Capital Expenditures	-2.70B
Free Cash Flow	-19.63B
FCF Per Share	-264.38

Full Cash Flow Statement

Margins

Gross margin is 36.68%, with operating and profit margins of -20.58% and -22.94%.

Gross Margin	36.68%
Operating Margin	-20.58%
Pretax Margin	-27.55%
Profit Margin	-22.94%
EBITDA Margin	-9.04%
EBIT Margin	-20.58%
FCF Margin	n/a

Dividends & Yields

LabGenomics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.39%
Shareholder Yield	n/a
Earnings Yield	-9.99%
FCF Yield	-9.72%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 7, 2023. It was a forward split with a ratio of 2.

Last Split Date	Aug 7, 2023
Split Type	Forward
Split Ratio	2

Scores

LabGenomics has an Altman Z-Score of 2.67 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.67
Piotroski F-Score	4